Page last updated: 2024-08-24

venlafaxine hydrochloride and Breast Cancer

venlafaxine hydrochloride has been researched along with Breast Cancer in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (56.00)29.6817
2010's9 (36.00)24.3611
2020's2 (8.00)2.80

Authors

AuthorsStudies
Esfandbod, M; Etesam, F; Taleghani, SY1
Avari, JN; Kotbi, N; Mora, HA1
Carpenter, JS; Kalesan, B; Pitta, DM; Ramaswami, R; Stebbing, J; Villarreal, MD1
Buijs, C; de Jong, RS; de Vries, EG; Marike Boezen, H; Maurer, JM; Mom, CH; Mourits, MJ; Nieboer, P; Willemse, PH; Wymenga, AN1
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V1
Barton, DL1
Ball, RM; Jakary, S; Kohn, B; Levine, RA; Nunez, R; Pegg, J; Peterson, E; Pocock, JR; Rodriguez, AI; Walker, EM1
Amr, YM; Yousef, AA1
Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM1
Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D1
Adriaansz, S; Beijnen, JH; Boekhout, AH; Dalesio, OB; Foekema-Töns, JH; Nuijen, B; Schellens, JH; Sprangers, S; van den Bosch, J; Vincent, AD1
Barton, DL; Loprinzi, CL; Qin, R1
Neher, JO; Sarkissian, A; Singh, R; St Anna, L1
Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A1
Sleijfer, DT; Wymenga, AN1
Goetz, MP; Loprinzi, CL1
Stearns, V1
Araba, A; Blanchard, R; Desta, Z; Flockhart, DA; Hayden, J; Hayes, DF; Ho, H; Jin, Y; Lee, KH; Lemler, S; Li, L; Nguyen, A; Rae, JM; Skaar, T; Stearns, V; Storniolo, AM; Ullmer, L; Ward, B; Weinshilboum, RM1
Bannink, M; Bontenbal, M; Seynaeve, C; van Gool, AR1
Biglia, N; Cacciari, F; Kubatzki, F; Maggiorotto, F; Ponzone, R; Roagna, R; Sismondi, P; Torta, R1
Azzouz, F; Carpenter, JS; Elam, JL; Johns, S; Johnson, CS; Monahan, PO; Shelton, RC; Storniolo, AM1
Kaufmann, M; Loibl, S; Mehta, KM; Schwedler, K; Strohmeier, R; von Minckwitz, G1
Barton, DL; Christensen, BJ; Dakhil, SR; Kugler, JW; LaVasseur, BI; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Rodger, K; Rummans, TA; Sloan, JA1
Härtel, B; Kalso, E; Tasmuth, T1

Reviews

6 review(s) available for venlafaxine hydrochloride and Breast Cancer

ArticleYear
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
    Breast cancer research and treatment, 2015, Volume: 152, Issue:2

    Topics: Breast Neoplasms; Disease Management; Female; Hot Flashes; Humans; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2015
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
    The American journal of psychiatry, 2008, Volume: 165, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride

2008
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
    The Journal of family practice, 2012, Volume: 61, Issue:12

    Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2012
Management of hot flushes in breast cancer patients.
    Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:3

    Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride

2002
A hot flash on tamoxifen metabolism.
    Journal of the National Cancer Institute, 2003, Dec-03, Volume: 95, Issue:23

    Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride

2003
Management of hot flashes in breast cancer survivors and men with prostate cancer.
    Current oncology reports, 2004, Volume: 6, Issue:4

    Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride

2004

Trials

11 trial(s) available for venlafaxine hydrochloride and Breast Cancer

ArticleYear
Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
    Drug research, 2023, Volume: 73, Issue:8

    Topics: Adult; Aged; Breast Neoplasms; Citalopram; Double-Blind Method; Female; Hot Flashes; Humans; Menopause, Premature; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride

2023
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
    Breast cancer research and treatment, 2009, Volume: 115, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Breast Neoplasms; Clonidine; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride

2009
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-01, Volume: 28, Issue:4

    Topics: Acupuncture Therapy; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome; Venlafaxine Hydrochloride

2010
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
    The Clinical journal of pain, 2010, Volume: 26, Issue:5

    Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride

2010
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35

    Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride

2010
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29

    Topics: Adult; Aged; Analgesics; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2011
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
    Maturitas, 2005, Sep-16, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Breast Neoplasms; Cyclohexanols; Drug Administration Schedule; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Survivors; Treatment Outcome; Venlafaxine Hydrochloride

2005
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    The oncologist, 2007, Volume: 12, Issue:1

    Topics: Adult; Breast Neoplasms; Cyclohexanols; Disease-Free Survival; Double-Blind Method; Female; Hot Flashes; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2007
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:4

    Topics: Adult; Aged; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2007
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
    Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247

    Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride

2000
Venlafaxine in neuropathic pain following treatment of breast cancer.
    European journal of pain (London, England), 2002, Volume: 6, Issue:1

    Topics: Analgesics; Breast Neoplasms; Cross-Over Studies; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Mastectomy; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Postoperative Complications; Treatment Outcome; Venlafaxine Hydrochloride

2002

Other Studies

8 other study(ies) available for venlafaxine hydrochloride and Breast Cancer

ArticleYear
Switch to Hypomania After Discontinuation of Tamoxifen: A Case Report.
    Journal of psychiatric practice, 2021, 01-21, Volume: 27, Issue:1

    Topics: Antidepressive Agents; Bipolar Disorder; Breast Neoplasms; Depressive Disorder; Female; Humans; Mania; Middle Aged; Tamoxifen; Venlafaxine Hydrochloride

2021
Menopausal symptoms following tamoxifen treatment for breast cancer.
    Oncology (Williston Park, N.Y.), 2008, Volume: 22, Issue:4 Suppl Nu

    Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride

2008
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
    Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins

2010
Nonestrogenic management of hot flashes.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29

    Topics: Breast Neoplasms; Clonidine; Cyclohexanols; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride

2011
Differences in clinician understanding and management of early menopause after breast cancer.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:4

    Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride

2013
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
    Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Arylsulfotransferase; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclohexanols; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Genotype; Humans; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Time Factors; Venlafaxine Hydrochloride

2005
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
    The Netherlands journal of medicine, 2005, Volume: 63, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Cyclohexanols; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride

2005
Breast cancer and hot flashes. Options for relief.
    Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3

    Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2001